These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 10866081

  • 1. Dynamic MR imaging of liver metastases with Gd-EOB-DTPA.
    Stern W, Schick F, Kopp AF, Reimer P, Shamsi K, Claussen CD, Laniado M.
    Acta Radiol; 2000 May; 41(3):255-62. PubMed ID: 10866081
    [Abstract] [Full Text] [Related]

  • 2. Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging.
    Reimer P, Rummeny EJ, Daldrup HE, Hesse T, Balzer T, Tombach B, Peters PE.
    Eur Radiol; 1997 May; 7(2):275-80. PubMed ID: 9038130
    [Abstract] [Full Text] [Related]

  • 3. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N, Persson A, Albiin N, Smedby O, Brismar TB.
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.
    Bluemke DA, Sahani D, Amendola M, Balzer T, Breuer J, Brown JJ, Casalino DD, Davis PL, Francis IR, Krinsky G, Lee FT, Lu D, Paulson EK, Schwartz LH, Siegelman ES, Small WC, Weber TM, Welber A, Shamsi K.
    Radiology; 2005 Oct; 237(1):89-98. PubMed ID: 16126918
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.
    Reimer P, Rummeny EJ, Shamsi K, Balzer T, Daldrup HE, Tombach B, Hesse T, Berns T, Peters PE.
    Radiology; 1996 Apr; 199(1):177-83. PubMed ID: 8633143
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. TWIST-VIBE five-arterial-phase technology decreases transient severe motion after bolus injection of Gd-EOB-DTPA.
    Li H, Xiao Y, Wang S, Li Y, Zhong X, Situ W, Xiao E, Zhang Z.
    Clin Radiol; 2017 Sep; 72(9):800.e1-800.e6. PubMed ID: 28476245
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration.
    Benndorf M, Schelhorn J, Dietzel M, Kaiser WA, Baltzer PA.
    Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, Kamura T, Gabata T, Murakami T, Ito K, Hirohashi S, Nishie A, Saito Y, Onaya H, Kuwatsuru R, Morimoto A, Ueda K, Kurauchi M, Breuer J.
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [Abstract] [Full Text] [Related]

  • 16. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
    Donati OF, Hany TF, Reiner CS, von Schulthess GK, Marincek B, Seifert B, Weishaupt D.
    J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
    [Abstract] [Full Text] [Related]

  • 17. Vascular enhancement in early dynamic liver MR imaging in an animal model: comparison of two injection regimen and two different doses Gd-EOB-DTPA (gadoxetic acid) with standard Gd-DTPA.
    Zech CJ, Vos B, Nordell A, Urich M, Blomqvist L, Breuer J, Reiser MF, Weinmann HJ.
    Invest Radiol; 2009 Jun; 44(6):305-10. PubMed ID: 19462484
    [Abstract] [Full Text] [Related]

  • 18. Radial MRI during free breathing in contrast-enhanced hepatobiliary phase imaging.
    Gomi T, Nagamoto M, Hasegawa M, Tabata A, Iwasaki M, Ooka M, Murata N, Tsunoo M, Iizuka Y, Kohda E, Shiraga N.
    Acta Radiol; 2014 Feb; 55(1):3-7. PubMed ID: 23873886
    [Abstract] [Full Text] [Related]

  • 19. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
    Lee S, Kim SH, Park CK, Kim YS, Lee WJ, Lim HK.
    J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
    [Abstract] [Full Text] [Related]

  • 20. Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid.
    Lin CY, Chang WC, Chou CT, Chen RC.
    J Chin Med Assoc; 2015 Nov; 78(11):666-72. PubMed ID: 26341453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.